Preemptive prophylaxis of migraine
US7189753B1 · kind B1 · utility
Inventors
Key dates
| Filing date | May 22, 2000 |
| Grant date | Mar 13, 2007 |
| Priority date | — |
| Expiry date | May 22, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/34
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of preventing the headache phase of migraine in a human comprises administration of a 5HT1 receptor agonist or administration of an over-the-counter or nonprescription drug to said human exhibiting prodrome symptoms of migraine. Suitably, the method comprises administration of a migraine headache phase-preventing effective amount of the 5HT1 agonist or over-the-counter or nonprescription drug. There is disclosed a preemptive prophylaxis migraine method using the following cognitive tests: Simple Reaction Time; Running Memory Continuous Performance Task; Matching to Sample; Mathematical Processing Task; and interpreting the results as a percent of baseline indicator of need for prophylaxis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.